Variability in the Treatment of Elderly Patients with Stage IIIA (N2) Non–Small-Cell Lung Cancer
Open Access
- 1 June 2013
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 8 (6) , 744-752
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Age Patterns of Incidence of Geriatric Disease in the U.S. Elderly Population: Medicare‐Based AnalysisJournal of the American Geriatrics Society, 2012
- The impact of socioeconomic status on stage of cancer at diagnosis and survivalCancer, 2010
- Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups?Cancer Causes & Control, 2010
- Multi-Modality Mediastinal Staging for Lung Cancer Among Medicare BeneficiariesJournal of Thoracic Oncology, 2009
- Racial Disparities Among Patients With Lung Cancer Who Were Recommended Operative TherapyArchives of Surgery, 2009
- Prognostic factors and long term results of neo adjuvant therapy followed by surgery in stage IIIA N2 non-small cell lung cancer patientsAnnals of Thoracic Medicine, 2009
- Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco ControlJNCI: Journal of the National Cancer Institute, 2008
- Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality StudyCancer Causes & Control, 2008
- Racial Differences in the Treatment of Early-Stage Lung CancerNew England Journal of Medicine, 1999
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987